Details of Drug-Drug Interaction
| Drug General Information (ID: DDIO70V59Q) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Cyclosporine | Drug Info | Griseofulvin | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antiviral Agents | Antifungal Agents | |||||||
| Structure | |||||||||
| Mechanism of Cyclosporine-Griseofulvin Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Decreased renal excretion (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Cyclosporine | Griseofulvin | |||||||
| Mechanism | Cyclosporine | Reduce the serum concentration of cyclosporine | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the excretion of the drug, resulting in changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Monitoring of cyclosporine levels during concomitant administration is recommended, as is close observation of the patient for signs of rejection or toxicity when griseofulvin is added to or discontinued from therapy. Dose adjustments may be required. | ||||||||
